| Source HCPCS Code |
|
Target NDC Code |
J2779
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
|
⇄
|
50242-0078-12
SUSVIMO 10 MG/0.1 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IL |
| Billing Units |
ML |
|
|
|
J2779
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
|
⇄
|
50242-0078-55
SUSVIMO 10 MG/0.1 ML KIT
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
KIT |
| Route Of Administration |
IL |
| Billing Units |
ML |
|
|
|
J2779
Inj, susvimo 0.1 mg
|
⇄
|
50242-0078-12
Susvimo
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J2779
Inj, susvimo 0.1 mg
|
⇄
|
50242-0078-55
Susvimo
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|